Author | Dr Fahd Quhill

Articles

Intravitreal implant could bring significant cost savings to NHS England

A study has revealed that a budgetary saving per treated patient with the fluocinolone acetonide implant (Iluvien) versus ranibizumab (Lucentis) could lead to a significant cost-saving to NHS England.